Post Reply
2961-2980 of 3013
I am also one of those contemplating to sell because first half report is flat. Actually, it is good after careful consideration. And, now with your information which puts it very clearly. Many thanks.
Acl2013 ( Date: 21-Aug-2020 08:03) Posted:
|
Should see rebound today....
wehuattogether88 ( Date: 18-Aug-2020 13:19) Posted:
|
Before you sell off the Frencken, see the fundamentals of it first, dont panic.
- NAV is $0.7458
- 1H20 profit 18.641 million
- EPS 1H20 is 4.41 cents , expect will be better by 2H20
- P/E ratio is x10.087
Many tech stock P/E is above x12 right now, glove stock is X38~107 and mask stock is x643!!
Maybank Kim Eng TP $1.33 (19/08 new)
CGS-CIMB TP $1.06 (14/08)
KGI securities TP $1.21 (17/08)
UOB Kay Hian TP $1.37 (14/08)
DBS research TP $1.43 (14/08)
So why sell off Frencken at this price?
Late morning went up above $1.00 briefly.
After that no strength.
After that no strength.
its nearest peer is UMS, now trade @ PE 15.x. This one PE @ 9.x. and good thing is its busniess less impact by trade war.
$3 very possible
A very very sound company
It?s very alike AEM in early days
A very very sound company
It?s very alike AEM in early days
Topic aim $1 already in history, let looking for the new horizon from now onwards.
patient168 ( Date: 18-Aug-2020 12:17) Posted:
|
Yes its for longer term.. not for contra
I like the new topic title, will hold for long term and hope another AEM is making.
I like this
It is just baby AEM in early days
Been holding since 80 cent
Will wait out for $2
The mgt is very good
It is just baby AEM in early days
Been holding since 80 cent
Will wait out for $2
The mgt is very good
There are not rate for fun!
CGS-CIMB TP $1.06
KGI securities TP $1.21
UOB Kay Hian TP $1.37
DBS research TP $1.43
Waiting for Kim Eng and RHB new rate.
Seems today is the day big fund loading and buying in..
heavy selling. 0.96 shd be a good entry point
| 1:53:56 | 0.995 | 2,000 | Buy Up |
| 11:52:16 | 0.995 | 20,000 | Buy Up |
| 11:52:08 | 0.995 | 100 | Buy Up |
| 11:51:58 | 0.995 | 5,000 | Sell Down |
| 11:51:58 | 0.995 | 100 | Sell Down |
| 11:51:58 | 0.995 | 1,300 | Sell Down |
Need a very strong hand to move. The sell queue depth volumns are very hugh.
Hopefully it will retest its recent high of $1.26. The sky is the limit.
It s rebound now, short term will be cover the gap at $1.160 to $1.180.
those panic to sell regrets now, and those short sell is losing their pants now.
those panic to sell regrets now, and those short sell is losing their pants now.
By DBS
Maintain BUY with higher TP of S$1.43 all key segments expected to post higher or at least stable revenue in 2H20 vs 1H20. We believe the worst is over for the supply chain. The initial supply chain disruptions caused by the COVID-19 lockdown measures are largely resolved. At present, all the Group&rsquo s manufacturing sites in Asia, Europe and the US have resumed normal operations. Demand is also gradually improving as Frencken expects higher or at least stable revenue in 2H20 as compared to 1H20. Frencken&rsquo s strong presence across a wide variety of industries and business segments should help to provide resilience and stability to the Group. Furthermore, it has good exposure of 30% revenue to the growing semiconductor segment (as at 1H20, up from 16% in 1H19).
At 14x FY20F and 11.5x FY21F earnings, Frencken is trading at about c.30% discount to its global peers&rsquo average of 16.5x PE. The stock is supported by a dividend yield of about 2% based on a 30% payout ratio.
Where we differ: We are optimistic that Frencken can tide over this period of extreme volatility given its diversified exposure.
Potential catalysts: 1) Sustained recovery of supply chain 2) Further positive developments on the US-China trade war front 3) Better operational efficiency to improve margins.
Valuation:
Maintain BUY with higher TP of S$1.43. We raised our TP to S$1.43 as we shift our valuation base to FY21F, pegged to 13.2x PE (previously 10.4x), at a 20% discount to peers&rsquo average given Frencken&rsquo s smaller scale.
Maintain BUY with higher TP of S$1.43 all key segments expected to post higher or at least stable revenue in 2H20 vs 1H20. We believe the worst is over for the supply chain. The initial supply chain disruptions caused by the COVID-19 lockdown measures are largely resolved. At present, all the Group&rsquo s manufacturing sites in Asia, Europe and the US have resumed normal operations. Demand is also gradually improving as Frencken expects higher or at least stable revenue in 2H20 as compared to 1H20. Frencken&rsquo s strong presence across a wide variety of industries and business segments should help to provide resilience and stability to the Group. Furthermore, it has good exposure of 30% revenue to the growing semiconductor segment (as at 1H20, up from 16% in 1H19).
At 14x FY20F and 11.5x FY21F earnings, Frencken is trading at about c.30% discount to its global peers&rsquo average of 16.5x PE. The stock is supported by a dividend yield of about 2% based on a 30% payout ratio.
Where we differ: We are optimistic that Frencken can tide over this period of extreme volatility given its diversified exposure.
Potential catalysts: 1) Sustained recovery of supply chain 2) Further positive developments on the US-China trade war front 3) Better operational efficiency to improve margins.
Valuation:
Maintain BUY with higher TP of S$1.43. We raised our TP to S$1.43 as we shift our valuation base to FY21F, pegged to 13.2x PE (previously 10.4x), at a 20% discount to peers&rsquo average given Frencken&rsquo s smaller scale.
Reload and ready...
Result actually ok yet got badly punished. Maybe tech stocks already over bought need correction.
Latest Tp $1.43 from vickers